US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 80.400
  • +0.750+0.94%
Close May 15 16:00 ET
  • 80.400
  • 0.0000.00%
Post 16:38 ET
15.27BMarket Cap75.85P/E (TTM)

Biomarin Pharmaceutical Key Stats

Biomarin Pharmaceutical Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Apr 24, 2024

Revenue(YoY)

648.83M

+8.79%
EPS(YoY)

0.46

+70.37%

Buy

May 1, 2024

Biomarin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 23 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 692.210M--
--2024/Q2-- / 661.582M--
Apr 24, 20242024/Q1648.833M / 651.814M--
Feb 22, 20242023/Q4646.207M / 636.926M--
Nov 1, 20232023/Q3581.329M / 607.756M--
Jul 31, 20232023/Q2595.275M / 595.238M--
Apr 26, 20232023/Q1596.415M / 570.392M--
Feb 27, 20232022/Q4537.538M / 538.236M--
Oct 26, 20222022/Q3505.344M / 515.859M--
Aug 3, 20222022/Q2533.798M / 521.930M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 692.210M--
--2024/Q2-- / 661.582M--
Apr 24, 20242024/Q1648.833M / 651.814M--
Feb 22, 20242023/Q4646.207M / 636.926M--
Nov 1, 20232023/Q3581.329M / 607.756M--
Jul 31, 20232023/Q2595.275M / 595.238M--
Apr 26, 20232023/Q1596.415M / 570.392M--
Feb 27, 20232022/Q4537.538M / 538.236M--
Oct 26, 20222022/Q3505.344M / 515.859M--
Aug 3, 20222022/Q2533.798M / 521.930M--

Unlock Free Earnings Estimates

Biomarin Pharmaceutical Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 1, 2024

Buy

  • Buy

    72.73%
  • Hold

    27.27%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg